Navigate to
-
Tap into our Expert Clinical Network Prime received a request for a nonformulary biologic in a young patient with severe Crohn’s disease, as the provider documented past failures of a biologic on...
-
Footnotes When we say we are different from our competition, we truly mean it. At Prime, we are driven by our purpose of providing the care we would want for our loved ones. Explore how we stay...
-
Year 2 Prime Therapeutics’ leading research shows 1 in 12 remain on a GLP-1 drug for obesity at three years. Findings also show improved persistence with high-potency, obesity-approved GLP-1...
-
Ashley Block Week of Service is an annual event that allows our employees to come together to support our five charity partners, many of which address the major health care conditions we help our...